Horses are just as much a part of New Mexico’s story as green chile and balloons. One local startup is hoping their research ...
Determined Stoke City fan Paul Parsons has been clocking up the miles as he looks to score for charity after being inspired by his friend's brave daughter. The 46-year-old had this week set off from ...
A King County jury has awarded $24 million to the family of a man who died a day after treatment at a Seattle stem cell ...
Columnist Robin Stemple knows that his physical challenges aren't his fault, but that doesn't make it any easier to avoid ...
Reported Promising Data for TN-201 and TN-401 Gene Therapies in Fourth Quarter of 2025; Additional Data Readouts and Pursuit of Regulatory ...
Robert F. Kennedy Jr. is waging a multifront war on vaccines, and confidence in them is waning. His main victims, of course, are kids — more than 3,000 measles cases have been reported since he took ...
Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced that it has entered into a securities ...
Vibativ, Sancuso, and new Talicia brand led revenue gains, with initial Talicia sales commencing in Q4. Balance Sheet ...
After the FDA’s first-ever public listening meeting on data-sharing in the cell and gene therapy space, new draft guidance aims to standardize the practice. But recent decisions call into question ...
Good afternoon, and welcome to Cumberland Pharmaceuticals 2025 Financial Report and Company Update. This call is being recorded at the company's request and will be archived on its website for 1 year ...
Controversial Yemassee 'monkey farm' announces plan to house retired scientific research monkeys from other facilities in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results